Company / Operating Margin
TELA Bio, Inc. Operating Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-75.4%
FY2025
5-year range
-138.8% / -75.4%
FY2021-FY2025
Trend
+19.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has increased for 3 consecutive years, from -138.8% in FY2022 to -75.4% in FY2025.
Based on SEC 10-K filings.
-75.4% in FY2025 with a 5-year CAGR of +139.5%.
Improved from -100.0% to -75.4% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +63.4pp
- 5-Year Change
- +139.5pp
- 10-Year Change
- -
Key checks
Key Insights
- TELA Bio, Inc.'s operating margin has grown for 3 consecutive years.
- In FY2025, operating margin increased 19.9% year-over-year.
- Lowest operating margin in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -75.4% | +19.9% |
| FY2024 | -94.2% | +5.8% |
| FY2023 | -100.0% | +28.0% |
| FY2022 | -138.8% | -11.9% |
| FY2021 | -124.1% | +42.3% |
| FY2020 | -214.9% | +46.1% |
| FY2019 | -398.7% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026